Providence Therapeutics (PTx) is a Canadian RNA medicines company focused on developing transformative vaccines for cancer treatment and protection against hard-to-treat infectious diseases. With operations in Calgary and Toronto, the company utilizes a robust, clinically proven ecosystem for the rapid development of mRNA-based therapeutics. Initially focused on personalized cancer vaccines, Providence pivoted to include COVID-19 vaccine development during the pandemic, showcasing its agility and commitment to addressing urgent health needs. The company aims to collaborate with industry players to expand its mRNA platform technology across various therapeutic areas, positioning itself as a leader in the biotech space.
Something looks off?On-site & Remote